[SaneVax: MenHibrix vaccine, manufactured by GlaxoSmithKline, was just approved for use in the U.S. based on data gathered from the inoculation of 7,521 infants and toddlers in five countries with ‘at least one dose.’ The problem is, this vaccine is given in a four dose regimen. How did the FDA determine that this vaccine was […]
The Hindu Thiruvananthapuram, December 18, 2011 Pentavalent vaccine safe, say health officials A high-level team consisting of experts from the Union Ministry of Health and the World Health Organisation (WHO) has started investigating into the sudden death of a 58-day-old baby at Vithura near here on Thursday. The death of the infant, which occurred […]
By Christina Dickenson FORT COLLINS – A clinic in Northern Colorado is advising parents of children who received a pediatric flu shot from their offices to get tested for some blood-borne diseases including HIV, Hepatitis B and Hepatitis C after their vaccine syringes were shared between patients. Med Peds Clinic of Fort Collins sent out […]
NEW YORK, NY–(Marketwire – April 11, 2011) – It is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. More than 1.2 million of these deaths, 90% of which occur in the developing world, are a result of pneumococcal diseases, according to the […]
Posted: March 18, 2011 05:46 PM
The Centers for Disease Control and Prevention wants to study autism as a possible clinical outcome of immunization, as part of its newly adopted 5-year research agenda for vaccine safety, the agency said on its website.
The CDC will also study mitochondrial dysfunction and the potential risk for post-vaccine “neurological deterioration,” and convene an expert panel on the feasibility of studying health outcomes such as autism among vaccinated and unvaccinated children.
The CDC plan adopts recommendations approved by the National Vaccine Advisory Committee of the US Department of Health and Human Services. It also comes one month after the federal government’s leading autism body, the Interagency Autism Coordinating Committee (IACC), announced a shift in research priorities toward environmental triggers for autism, which the IACC said could include toxins, biological agents and “adverse events following immunization.”
The Centers for Disease Control and Prevention’s Immunization Safety Office Scientific Agenda indentified the need to research “Neurodevelopmental disorders, including autism spectrum disorder (ASD)” as a possible clinical outcome of vaccination.